Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 10.83 -1.37% -0.15
ALDR closed down 1.37 percent on Friday, May 17, 2019, on 69 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALDR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.37%
Wide Bands Range Expansion -1.37%
Up 3 Days in a Row Strength -1.37%
Oversold Stochastic Weakness -1.37%
Stochastic Buy Signal Bullish -1.10%
Narrow Range Bar Range Contraction -1.10%
NR7 Range Contraction -1.10%
NR7-2 Range Contraction -1.10%

Older signals for ALDR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Medicine Biotechnology Health Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Rheumatoid Arthritis Bristol Myers Squibb Migraine Prevention Of Migraine Psoriatic Arthritis
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.869
52 Week Low 9.44
Average Volume 934,972
200-Day Moving Average 13.9416
50-Day Moving Average 12.9314
20-Day Moving Average 12.3205
10-Day Moving Average 11.403
Average True Range 0.6153
ADX 24.21
+DI 13.3165
-DI 28.7993
Chandelier Exit (Long, 3 ATRs ) 12.3541
Chandelier Exit (Short, 3 ATRs ) 12.4559
Upper Bollinger Band 14.5743
Lower Bollinger Band 10.0667
Percent B (%b) 0.17
BandWidth 36.586178
MACD Line -0.6525
MACD Signal Line -0.4888
MACD Histogram -0.1637
Fundamentals Value
Market Cap 733.34 Million
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -2.11
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.49
Resistance 3 (R3) 11.50 11.28 11.38
Resistance 2 (R2) 11.28 11.12 11.28 11.34
Resistance 1 (R1) 11.06 11.01 10.95 11.05 11.31
Pivot Point 10.84 10.84 10.79 10.84 10.84
Support 1 (S1) 10.62 10.68 10.51 10.61 10.35
Support 2 (S2) 10.40 10.57 10.40 10.32
Support 3 (S3) 10.18 10.40 10.28
Support 4 (S4) 10.17